PRESS RELEASE
News
-
-
PRESS RELEASE
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
Telomir Pharmaceuticals, Inc. appoints Dr. Itzchak Angel as Chief Scientific Advisor to lead developments in longevity science and advance Telomir-1 small molecule for age-related conditions in humans and animals -
-
PRESS RELEASE
The NAGA Group enters sponsoring partnership with German Bundesliga football team Borussia Dortmund
The NAGA Group AG partners with Borussia Dortmund, entering a sponsorship deal for the Bundesliga season 2025/2026. The partnership aims to boost brand awareness and target new audiences globally -
-
PRESS RELEASE
EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11%
EV Nickel Inc. reports high-grade nickel intercepts including 5.11% Ni in Langmuir #2 Nickel Zone, with assay results indicating high nickel tenor. Company plans further drilling to advance Canadian nickel supply chain -
-
PRESS RELEASE
BeMetals Commences Follow-Up Drilling Program at Pangeni Copper Project, Zambia
BeMetals Corp. announces commencement of new exploration drilling program at Pangeni Copper Project in Zambia to expand copper mineralization zones and test satellite targets. Positive results from recent drilling also revealed -
-
PRESS RELEASE
Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome
Immunic announces enrollment of the first patient in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium for Post COVID Syndrome. Study aims to suppress EBV reactivation and fatigue symptoms
